Himadri Speciality Chemicals: FY26 profit surge lifts stock

Stock outperforms as markets stay choppy

Himadri Speciality Chemicals Ltd has drawn investor attention after a sharp run-up in recent months, even as broader indices saw periods of weakness. BSE Analytics data cited in the report shows the stock delivering a 50% return over the last three months, more than 44% over six months, and over 36% year-to-date (YTD) in 2026. The rally has been linked to a mix of strong earnings prints, record full-year profitability and company expansion updates.

Even on sessions where the stock stayed in the red due to profit booking, it continued to hit new highs. One update noted the stock made a 52-week high on Monday, rising 5.75% to Rs 642.60 intraday before giving up gains and slipping to Rs 587.40. Another report described a separate spike of nearly 13% on April 24, taking the stock to an intraday peak of Rs 604.75.

What triggered the latest spike and subsequent profit booking

The immediate trigger highlighted across the reports was the company’s quarterly earnings and commentary around expansion plans. The move to record levels was followed by selling pressure, suggesting near-term traders booked profits after a steep run.

One data point in the article states the stock rallied about 45% in the last one month. Another states it surged more than 45% from Rs 441.60 (close on March 30) to subsequent levels, underlining the speed of the move. Despite the pullback from intraday highs, the stock continued to trade at elevated levels versus late March.

FY26: record EBITDA and PAT on Rs 4,661 crore revenue

The company’s full-year numbers were a key part of the narrative. For FY26, Himadri Speciality Chemicals reported revenue (turnover) of Rs 4,661 crore, record EBITDA of Rs 1,006 crore, and record PAT of Rs 755 crore. Another FY26 snapshot in the material listed revenue from operations at Rs 4,660.7 crore (vs Rs 4,612.63 crore in FY25), PBT at Rs 1,000.9 crore (vs Rs 806.17 crore), and PAT at Rs 755.07 crore (vs Rs 555.09 crore).

The reports also noted that FY26 EBITDA was up 19% year-on-year, and FY26 PAT rose 36% year-on-year. EPS for FY26 was stated at Rs 15.08.

Q4 FY26: profit growth, revenue expansion, and margin watch

The Q4 FY26 performance was presented as another catalyst for the rally. The company reported a 29% year-on-year rise in net profit to about Rs 200.8 crore (also cited as Rs 201 crore in one update), while revenue rose 13.5% to about Rs 1,287.75 crore (also cited as Rs 1,288 crore).

EBITDA was reported at Rs 280 crore in one section, up 21% year-on-year, with margin at 18.8%. Another section cited EBITDA of Rs 242 crore with an 18.8% margin and said the margin narrowed from 20.6%. Separately, a note said EBITDA performance was impacted by a forex loss of INR 0.4 billion, which is Rs 40 crore when expressed in Rs crore.

The prior-year Q4 FY25 PAT was referenced at Rs 155.58 crore, supporting the stated year-on-year growth.

Dividend announcement adds support

Alongside earnings, the company announced a final dividend of Rs 0.80 per share for FY26. The combination of stronger profitability and shareholder payouts helped reinforce positive sentiment in the immediate aftermath of the results.

Expansion update: first anode material facility in West Bengal

One of the updates linked the rally to the launch of Himadri Speciality Chemical’s first anode material facility in West Bengal. In that report, the stock’s jump was said to have added about Rs 3,500 crore to the company’s market value, taking total market capitalisation to Rs 30,624 crore.

While the story did not quantify capacity or timelines for the facility, it positioned the launch as a strategic step that investors responded to quickly in the market.

Guidance: goal to double profit by FY28 versus FY25

The company’s guidance also featured prominently. As per the provided text, Himadri has targeted doubling profit by FY28 compared with FY25. That goal was cited as a reason investor confidence strengthened after the FY26 performance.

Broker view: IDBI Capital’s buy call with stop loss and target

IDBI Capital Markets and Securities’ AVP (Derivatives and Retail Research) Sachin Janardan Sarvade was cited advising buying at current levels. The report mentioned a stop loss of Rs 579 and a target price of Rs 900.

Where the stock traded during the updates

A price snapshot provided in the material said that at 11:27 am, the stock was down about 1% on BSE, trading at Rs 661.40 (down Rs 6.65), while on NSE it was down 0.88% at Rs 661.30 (down Rs 5.90).

A separate return table included in the text showed different period returns for the stock at another point in time: 1 day -1.02%, 1 week -6.61%, 1 month -0.53%, 3 months -5.02%, 1 year 3.76%, 3 years 417.78%, and 5 years 890.81%. The same compilation also displayed an illustrative last-traded price of Rs 452.65 versus a previous close of Rs 457.45, reflecting that the source data points were drawn from different dates and market snapshots.

Key numbers at a glance

Why the results mattered for market sentiment

The reported record FY26 EBITDA and PAT gave investors a clear datapoint that profitability improved even when revenue growth for the year was modest in one of the summaries. Q4 showed double-digit revenue growth and strong profit expansion, though margin commentary and the forex loss reference indicate the quarter also had cost and currency factors in play.

The guidance to double profit by FY28 versus FY25 set a longer runway for expectations, while the anode material facility launch added an expansion narrative to the earnings story. Taken together, these were the principal, fact-based drivers mentioned for the stock’s outperformance versus the market during the period.

Conclusion

Himadri Speciality Chemicals’ rally to fresh highs has been supported by record FY26 profitability, a strong Q4 earnings print, a final dividend for FY26, and expansion news tied to its anode material facility in West Bengal. Near-term price action has also shown profit booking after sharp run-ups, even as broker commentary cited specific stop loss and target levels. Investors will likely track subsequent quarterly updates and any further disclosures around the company’s expansion plans and progress against its FY28 profit-doubling guidance.